KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:ARGS
Delisted

Argos Therapeutics Fund Price (Quote)

$0.0536
+0 (+0%)
At Close: Apr 15, 2020

Range Low Price High Price Comment
30 days $0.0536 $0.0536 Wednesday, 15th Apr 2020 ARGS stock ended at $0.0536. During the day the stock fluctuated 0% from a day low at $0.0536 to a day high of $0.0536.
90 days $0.0536 $0.0536
52 weeks $0.0350 $0.0840

Historical Argos Therapeutics prices

Date Open High Low Close Volume
Jul 05, 2017 $7.22 $7.40 $7.02 $7.16 27 359
Jul 03, 2017 $7.80 $7.80 $7.04 $7.10 18 220
Jun 30, 2017 $7.30 $7.42 $7.00 $7.26 25 694
Jun 29, 2017 $7.80 $7.80 $7.00 $7.02 28 160
Jun 28, 2017 $7.88 $7.88 $7.40 $7.52 19 243
Jun 27, 2017 $7.80 $8.00 $7.40 $7.60 19 964
Jun 26, 2017 $8.20 $8.22 $7.40 $7.62 45 505
Jun 23, 2017 $9.40 $9.40 $7.80 $7.80 116 819
Jun 22, 2017 $8.80 $9.60 $8.20 $8.34 38 343
Jun 21, 2017 $8.40 $10.40 $8.20 $9.00 96 852
Jun 20, 2017 $8.24 $9.10 $8.20 $8.57 34 686
Jun 19, 2017 $7.80 $8.36 $7.80 $8.18 11 028
Jun 16, 2017 $8.20 $8.20 $7.80 $7.80 11 678
Jun 15, 2017 $8.20 $8.20 $7.82 $7.85 8 848
Jun 14, 2017 $8.00 $8.20 $7.80 $8.16 13 426
Jun 13, 2017 $8.20 $8.20 $7.82 $8.02 8 929
Jun 12, 2017 $8.20 $8.40 $8.00 $8.07 6 069
Jun 09, 2017 $8.40 $8.60 $8.00 $8.16 23 715
Jun 08, 2017 $8.16 $8.20 $8.00 $8.15 4 956
Jun 07, 2017 $8.04 $8.22 $7.90 $8.12 8 942
Jun 06, 2017 $8.20 $8.40 $8.00 $8.20 16 631
Jun 05, 2017 $8.34 $8.42 $8.20 $8.35 8 465
Jun 02, 2017 $9.10 $9.10 $8.22 $8.54 21 838
Jun 01, 2017 $8.80 $9.80 $8.42 $8.77 51 675
May 31, 2017 $8.30 $8.80 $8.30 $8.70 11 612
Click to get the best stock tips daily for free!

About Argos Therapeutics

Argos Therapeutics, Inc. focuses on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases in North America. The company develops immunotherapies based on Arcelis, its proprietary technology platform. Its development stage products include AGS-003, which is under Phase III clinical trials for the treatment of metastatic renal cell carcinoma and other cancers; and AGS-004, which ... ARGS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT